Recruiting

Tampon Safety

Sponsor:

Kimberly-Clark Corporation

Code:

NCT07561905

Conditions

Menstruation

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Accepted

Interventions

Tampon A

Study Details

Brief summary:

The goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle.

Conditions

Menstruation

Study ID

NCT07561905

Start date

May 12, 2026

Status verified date

Aug, 2026

Completion date

Sep 7, 2026

Anticipated

Primary completion date

Aug 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Accepted

Key Inclusion Criteria:

  • Willing and able to read and provide written informed consent.
  • Female in good general health, age 18-49 (inclusive).
  • History of regular menstrual cycles during the previous 3months lasting approximately 21-35 days, including at least 4 days of menstruation, and expecting to menstruate during the study period.
  • History of use of applicator tampons within the past 12 months without discomfort.
  • Tracks menstruation and be able to confidently predict onset of menstruation
  • Normally use at least 6 tampons for protection during menstruation.
  • Normally uses regular, super, and/or super plus absorbency tampons for menstrual protection.
  • Agrees to the conduct of all study procedures, including gynecological exams and agrees to follow all study instructions and return for scheduled appointments.
  • Has used an acceptable form of birth control for at least one month prior to enrollment and for the duration of the study.

Key Exclusion Criteria:

  • Pregnant, lactating or is trying to become pregnant.
  • Less than six (6) weeks post-partum.
  • Has a menstrual abnormality (such as oligomenorrhea or amenorrhea).
  • Has a known allergy or sensitivity to components of the investigational products
  • Any other medical condition or history, as determined by the Investigator that could compromise the study results or subject safety.

Study Design

Enrollment

60 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Test Tampon

Interventions

Tampon A

Commercially available tampons in regular, super, and super plus absorbencies

Primary outcome measure

  • Incidence of Tampon Related Adverse Events [ Time Frame: From enrollment to 7 days post last visit ]

Central Contacts and Locations

Locations

Princeton Consumer Research

Recruiting

St. Petersburg, Florida, United States, 33702

Contacts

Christine Maraghy

727-576-7300info@princetonconsumer.com

Principal Investigator:

Christine Maraghy

More Information

Sponsor

Kimberly-Clark Corporation

Last update posted

Aug 10, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Kimberly-Clark Corporation on 2026-08-10.